{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T06:42:12Z","timestamp":1697265732679},"reference-count":26,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T00:00:00Z","timestamp":1089072000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>1.\u2002In a double\u2010blind randomized controlled design, 50 children were allocated to receive bupivacaine 0.25% or ropivacaine 0.25%, 0.32%, 0.40% or 0.50% by caudal block.<\/jats:p><jats:p>2.\u2002Caudal block was performed after induction of anaesthesia with 2\u20135% sevoflurane, atropine 10\u00a0\u00b5g\/kg and midazolam 100\u2013300\u00a0\u00b5g\/kg. During the surgical procedure, patients were maintained under spontaneous ventilation and no intravenous or inhalatory anaesthetic agent was administered. For transoperative sedation, midazolam 100\u2013300\u00a0\u00b5g\/kg was administered every 0.5\u20131.0\u00a0h. Transoperative cardiovascular response, postoperative analgesia and local and systemic complications were evaluated.<\/jats:p><jats:p>3.\u2002Groups were similar (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.05) in sex, age, weight and in the time elapsed from caudal block to the beginning of the surgical procedure. The surgical time was significantly lower in the ropivacaine 0.25% group. The duration of analgesia was 24\u00a0h with ropivacaine 0.25% and approximately 10\u00a0h in the other four groups (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001). Linear regression analysis revealed a significant relationship between the postoperative analgesic period produced by ropivacaine and the surgical time (<jats:italic>r\u00a0=<\/jats:italic>\u00a0\u2212\u00a00.48, two\u2010sided <jats:italic>P<\/jats:italic>\u00a0=\u00a00.002). Systolic and diastolic blood pressures remained in the physiologically normal range for the duration of the transoperative period. Vomiting was present in only one patient receiving ropivacaine 0.50%.<\/jats:p><jats:p>4.\u2002In children, the duration of analgesia produced by caudal block with ropivacaine may be affected by surgical time. At surgical times of 0.5\u20131\u00a0h, ropivacaine 0.25% produced at least 24\u00a0h postoperative analgesia. At similar surgical times, ropivacaine 0.32%, 0.40% and 0.50% produced similar analgesic times to bupivacaine 0.25%.<\/jats:p>","DOI":"10.1111\/j.1440-1681.2004.04020.x","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T07:21:39Z","timestamp":1089098499000},"page":"462-465","source":"Crossref","is-referenced-by-count":3,"title":["DOSE\u2013RESPONSE OF ROPIVACAINE ADMINISTERED CAUDALLY TO CHILDREN UNDERGOING SURGICAL PROCEDURES UNDER SEDATION WITH MIDAZOLAM"],"prefix":"10.1111","volume":"31","author":[{"given":"F Tonatiu","family":"Aguirre\u2010Garay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A","family":"Nava\u2010Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1136","article-title":"Caudal anaesthesia in neonates and infants","volume":"35","author":"Caims C","year":"1980","journal-title":"Anaesthesia"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198902000-00024"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199508000-00020"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199208000-00024"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199308000-00029"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199311000-00030"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199208000-00023"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1982.tb01812.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/80.4.507"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.1999.tb00491.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/89.5.707"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.21614"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2002.00855.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198509001-00463"},{"key":"e_1_2_6_16_2","first-page":"45","article-title":"Evaluation of an objective pain scale for infants and children","volume":"13","author":"Broadman L","year":"1988","journal-title":"Reg. Anesth."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2000.00532.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199905000-00018"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/81.2.247"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/rapm.2002.30706"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199911000-00018"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2004.03961.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835010-00003"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199501000-00026"},{"key":"e_1_2_6_25_2","first-page":"955","article-title":"Ropivacaine, a new amide\u2010type local anesthetic agent, is metabolized by cytochromes P4501A and 3A in human liver microsomes","volume":"24","author":"Ekstr\u00f6m G","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_6_26_2","first-page":"962","article-title":"Metabolism and excretion of ropivacaine in humans","volume":"24","author":"Halldin MM","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2003.01063.x"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2004.04020.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2004.04020.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:22:11Z","timestamp":1697239331000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2004.04020.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1440-1681.2004.04020.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2004.04020.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}